Author name: admin

Satya is attending ASCO in Chicago with a focus on DDR space. To set up a meeting contact CSN at murthycsn@satyarx.com.

Abstract title Preclinical profile of novel and potent small molecule inhibitors of PARG Poster number 7112 Session title DNA Damage and Repair                             Session date and time April 10, 9:00 AM – 12:30 PM Session category Experimental and Molecular therapeutics Abstract title: Preclinical profile of novel and potent small molecule inhibitors of PARG Abstract:Poly(ADP-ribose) glycohydrolase (PARG) is

Satya had meetings with potential partners and collaborators to discuss its portfolio of programs during the JPM. A number of programs and collaboration ideas were discussed and would expand our agenda for 2024 and beyond.

  Abstract title SAT-122, a potential first-in-class, potent, small-molecule disruptor of RAD51-BRCA2, attenuates RAD51 foci formation and tumor progression in preclinical models Poster number FPN: 35P Publication category Basic science  Session date and time Sunday, October 22 | 9:00 am-5:00 pm Session location Hall 8 Abstract title: SAT-122, a potential first-in-class, potent, small-molecule disruptor of RAD51-BRCA2,

  Abstract title Best in class, potent, SOS1 inhibitors demonstrate single agent activity in preclinical models of KRAS driven tumors Poster number A099 Session Poster Session A                              Session date and time Thursday, October 12 | 12:30 pm-4:00 pm Session location Level 2, Exhibit Hall D Abstract title: Best in class, potent, SOS1 inhibitors demonstrate single agent activity

  Abstract title Preclinical profile of novel and potent small molecule inhibitors of KIF18A inhibitors in chromosomally unstable solid tumor lines Poster number A024 Session Poster Session A                              Session date and time Thursday, October 12 | 12:30 pm-4:00 pm Session location Level 2, Exhibit Hall D Abstract title: Preclinical profile of novel and potent small molecule inhibitors